{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:20:56Z","timestamp":1787498456192,"version":"build-2736575974"},"reference-count":206,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Non-infectious choroiditis comprises immune-mediated diseases resulting from diverse pathophysiological mechanisms. These conditions are sub-divided into two main groups, (1) diseases of the choriocapillaris and (2) diseases of the choroidal stroma. The purpose of this study is to expose the pathophysiology of the most common diseases of both these groups and recommend the optimal immunomodulatory\/immunosuppressive therapy of each analyzed condition based on literature data and data from our own centers. Material and Methods: Narrative review. In the group of choriocapillaritis entities or primary inflammatory choriocapillaropathies (PICCPs) including multiple evanescent white dot syndrome (MEWDS), acute posterior multifocal placoid pigment epitheliopathy (APMPPE), idiopathic multifocal choroiditis (MFC) and serpiginous choroiditis (SC), as well as secondary choriocapillaritides including acute syphilitic posterior multifocal placoid chorioretinitis (ASPMPC) and tuberculosis-related SC (TB-SC), were analyzed. In the group of stromal choroidites, HLA-A29 birdshot retinochoroiditis (BRC) and Vogt-Koyanagi-Harada (VKH) disease were included. For each entity a literature search, in the PubMed database, on treatment was performed and analyzed and the therapeutic attitudes of our own centers were presented. Management of immune-mediated choroiditis implies vigorous immunosuppressive therapy given in a prompt and prolonged fashion in most of these entities.<\/jats:p>","DOI":"10.3390\/ph15040398","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T23:31:43Z","timestamp":1648164703000},"page":"398","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mechanisms, Pathophysiology and Current Immunomodulatory\/Immunosuppressive Therapy of Non-Infectious and\/or Immune-Mediated Choroiditis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8930-5112","authenticated-orcid":false,"given":"Ioannis","family":"Papasavvas","sequence":"first","affiliation":[{"name":"Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialized Care (COS), Rue Charles-Monnard 6, CH-1003 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilknur","family":"Tugal-Tutkun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University, Istanbul 34093, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Carl P.","family":"Herbort","sequence":"additional","affiliation":[{"name":"Retinal and Inflammatory Eye Diseases, Centre for Ophthalmic Specialized Care (COS), Rue Charles-Monnard 6, CH-1003 Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.2174\/1381612821666150909094907","article-title":"Controversies in the Pharmacological Treatment of Uveitis","volume":"21","author":"Barry","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.semarthrit.2020.08.010","article-title":"Efficacy and safety of immunomodulatory drugs in patients with non-infectious intermediate and posterior uveitis, panuveitis and macular edema: A systematic literature review","volume":"50","author":"Loza","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1080\/09273948.2020.1727530","article-title":"Systemic Immunosuppression Is Highly Effective in the Long-term Control of Inflammatory non-infectious Uveitic Choroidal Neovascularization: A Comparative Study","volume":"29","author":"Neri","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/09273948.2020.1793369","article-title":"Definition of Uveitis Refractory to Treatment: A Systematic Review in the Absence of a Consensus","volume":"30","author":"Valenzuela","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Herbort, C., Mantovani, A., Tugal-Tutkun, I., and Papasavvas, I. (2021). Classification of Non-Infectious and\/or Immune Mediated Choroiditis: A Brief Overview of the Essentials. Diagnostics, 11.","DOI":"10.3390\/diagnostics11060939"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Papasavvas, I., and Herbort, C.P. (2022). Diagnosis and Treatment of Primary Inflammatory Choriocapillaropathies (PICCPs): A Comprehensive Overview. Medicina, 58.","DOI":"10.3390\/medicina58020165"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e19794","DOI":"10.1097\/MD.0000000000019794","article-title":"A CARE-compliant article: A case report of possible association between recurrence of multiple evanescent white dot syndrome and the Herpesviridae family","volume":"99","author":"Haw","year":"2020","journal-title":"Medicine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12348-021-00279-7","article-title":"Multiple evanescent white dot syndrome (MEWDS): Update on practical appraisal, diagnosis and clinicopathology; a review and an alternative comprehensive perspective","volume":"11","author":"Papasavvas","year":"2021","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12348-021-00263-1","article-title":"Acute posterior multifocal placoid pigment epitheliopathy (APMPPE)","volume":"11","author":"Testi","year":"2021","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12348-021-00278-8","article-title":"Idiopathic multifocal choroiditis (MFC): Aggressive and prolonged therapy with multiple immunosuppressive agents is needed to halt the progression of active disease. An offbeat review and a case series","volume":"12","author":"Papasavvas","year":"2022","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/ijo.IJO_822_18","article-title":"Enigma of serpiginous choroiditis","volume":"67","author":"Biswas","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4274\/tjo.37630","article-title":"Treatment Results in Serpiginous Choroiditis and Multifocal Serpiginoid Choroiditis Associated with Latent Tuberculosis","volume":"47","author":"Oray","year":"2017","journal-title":"Turk. J. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ajo.2011.05.004","article-title":"Continuous Progression of Tubercular Serpiginous-like Choroiditis After Initiating Antituberculosis Treatment","volume":"152","author":"Gupta","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/JOCO.JOCO_184_20","article-title":"Choriocapillaris involvement in acute syphilis posterior placoid chorioretinitis is responsible for functional impairment and points towards an immunologic mechanism: A comprehensive clinicopathological approach","volume":"32","author":"Herbort","year":"2020","journal-title":"J. Curr. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13023-016-0412-4","article-title":"Vogt-Koyanagi-Harada disease: Review of a rare autoimmune disease targeting antigens of melanocytes","volume":"11","author":"Lavezzo","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Papadia, M., Pav\u00e9sio, C., Fardeau, C., Neri, P., Kestelyn, P., Papasavvas, I., and Herbort, C. (2021). HLA-A29 Birdshot Retinochoroiditis in Its 5th Decade: Selected Glimpses into the Intellectual Meanderings and Progresses in the Knowledge of a Long-Time Misunderstood Disease. Diagnostics, 11.","DOI":"10.3390\/diagnostics11071291"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjo.79.9.856","article-title":"Fundal white dots: The spectrum of a similar pathological process","volume":"79","author":"Ezra","year":"1995","journal-title":"Br. J. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10792-021-02121-4","article-title":"\u201cWhite dot syndromes\u201d, an inappropriate and outdated misnomer","volume":"42","author":"Neri","year":"2021","journal-title":"Int. Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0161-6420(98)93024-X","article-title":"Schematic interpretation of indocyanine green angiography in posterior uveitis using a standard angiographic protocol","volume":"105","author":"Herbort","year":"1998","journal-title":"Ophthalmology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0031-1299394","article-title":"Classification of Choroiditis Based on Inflammatory Lesion Process rather than Fundus Appearance: Enhanced Comprehension through the ICGA Concepts of the Iceberg and Jellyfish Effects","volume":"229","author":"Herbort","year":"2012","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1055\/a-0829-6763","article-title":"Vogt-Koyanagi-Harada Disease and Birdshot Retinochoroidopathy, Similarities and Differences: A Glimpse into the Clinicopathology of Stromal Choroiditis, a Perspective and a Review","volume":"236","author":"Elahi","year":"2019","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/IIO.0b013e318265d48b","article-title":"Use of Indocyanine Green Angiography in Uveitis","volume":"52","author":"Herbort","year":"2012","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12348-021-00274-y","article-title":"Clinicopathology of non-infectious choroiditis: Evolution of its appraisal during the last 2\u20133 decades from \u201cwhite dot syndromes\u201d to precise classification","volume":"11","author":"Herbort","year":"2021","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/bjophthalmol-2018-312569","article-title":"Ultra-wide-field angiography findings in acute Vogt-Koyanagi-Harad disease","volume":"103","author":"Kim","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/aos.12974","article-title":"Indocyanine green angiographic findings in initial-onset acute Vogt-Koyanagi-Harada disese","volume":"94","author":"Abouammoh","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10384-010-0853-6","article-title":"Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients","volume":"54","author":"Miyanaga","year":"2010","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10792-016-0303-7","article-title":"Enhanced depth imaging is less suited than indocyanine green angiography for close monitoring of primary stromal choroiditis: A pilot report","volume":"37","author":"Balci","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"ref_28","first-page":"241","article-title":"Indocyanine Green Angiography Guided Management of Vogt-Koyanagi-Harada Disease","volume":"6","author":"Bouchenaki","year":"2011","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00127644","article-title":"Acute multifocal ischaemic choroidopathy and the choriocapillaris","volume":"6","author":"Deutman","year":"1983","journal-title":"Int. Ophthalmol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/IAE.0b013e3181c596f8","article-title":"Subretinal fluid in acute posterior multifocal placoid pigment epitheliopathy","volume":"30","author":"Birnbaum","year":"2010","journal-title":"Retina"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00417-015-3205-x","article-title":"Interpretation of fundus autofluorescence changes in choriocapillaritis: A multi-modality imaging study","volume":"254","author":"Mantovani","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/09273948.2013.855797","article-title":"Fundus Autofluorescence Imaging in Multifocal Choroiditis: Beyond the Spots","volume":"22","author":"Kramer","year":"2014","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1097\/OPX.0b013e31828d7d53","article-title":"Resolution of Acute Photoreceptor Damage as Revealed by Serial SD-OCT","volume":"90","author":"Sakai","year":"2013","journal-title":"Optom. Vis. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.3928\/15428877-20120816-01","article-title":"OCT Findings in Birdshot Chorioretinitis: A Glimpse Into Retinal Disease Evolution","volume":"43","author":"Papadia","year":"2012","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajo.2008.05.032","article-title":"Enhanced Depth Imaging Spectral-Domain Optical Coherence Tomography","volume":"146","author":"Spaide","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/eye.2017.54","article-title":"Evolution of choroidal thickness over time and effect of early and sustained therapy in birdshot retinochoroiditis","volume":"31","author":"Skvortsova","year":"2017","journal-title":"Eye"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.survophthal.2018.11.002","article-title":"Choroidal imaging biomarkers","volume":"64","author":"Singh","year":"2019","journal-title":"Surv. Ophthalmol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"OCT27","DOI":"10.1167\/iovs.15-19043","article-title":"Optical Coherence Tomography Angiography","volume":"57","author":"Gao","year":"2016","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/ICB.0000000000000512","article-title":"Serpiginous choroiditis imaged by optical coherence tomography angiography","volume":"12","author":"Herbort","year":"2018","journal-title":"Retin. Cases Brief Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10792-008-9263-x","article-title":"Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis)","volume":"30","author":"Herbort","year":"2010","journal-title":"Int. Ophthalmol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.joco.2018.12.006","article-title":"Sensitivity of indocyanine green angiography compared to fluorescein angiography and enhanced depth imaging optical coherence tomography during tapering and fine-tuning of therapy in primary stromal choroiditis: A case series","volume":"31","author":"Elahi","year":"2019","journal-title":"J. Curr. Ophthalmol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10792-008-9288-1","article-title":"Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease","volume":"30","author":"Kawaguchi","year":"2010","journal-title":"Int. Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0025-6196(12)65130-1","article-title":"Endogenous Uveitis: Current Concepts of Treatment","volume":"65","author":"Herman","year":"1990","journal-title":"Mayo Clin. Proc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0002-9394(63)91858-0","article-title":"Changes in the Intraocular Pressure associated with systemic corticosteroid therapy","volume":"56","author":"Alfano","year":"1963","journal-title":"Am. J. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-2002-30660","article-title":"Corticosteroid-induced central serous chorioretinopathy in patients with ocular inflammatory disorders","volume":"219","author":"Schalenbourg","year":"2002","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1067\/mjd.2000.103980","article-title":"Screening for azathio-prine toxicity: A pharmacoeconomic analysis based on a target case","volume":"42","author":"Tavadia","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_47","first-page":"499","article-title":"Treatment of uveitis with azathioprine (Imuran)","volume":"87","author":"Newell","year":"1967","journal-title":"Trans. Ophthalmol. Soc. UK"},{"key":"ref_48","unstructured":"World Health Organization (2021). World Health Organization Model List of Essential Medicines\u201322nd List, World Health Organization."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0014-4835(05)80138-1","article-title":"Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism","volume":"61","author":"Chanaud","year":"1995","journal-title":"Exp. Eye Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0161-6420(03)00092-7","article-title":"Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders","volume":"110","author":"Baltatzis","year":"2003","journal-title":"Ophthalmology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/TP.0b013e31822527ca","article-title":"Gastrointestinal Quality of Life Improvement of Renal Transplant Recipients Converted From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Drugs or Agents: Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium","volume":"92","author":"Ortega","year":"2011","journal-title":"Transplantation"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Zierhut, M., Pav\u00e9sio, C., Ohno, S., Or\u00e9fice, F., and Rao, N.A. (2016). Methotrexate. Intraocular Inflammation, Springer.","DOI":"10.1007\/978-3-540-75387-2"},{"key":"ref_53","first-page":"9","article-title":"Serpiginous choroiditis treated in a stepladder approach","volume":"306","author":"Depla","year":"2007","journal-title":"Bull. Soc. Belge Ophtalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"bcr2015212526","DOI":"10.1136\/bcr-2015-212526","article-title":"Multifocal chorioretinitis with progressive subretinal fibrosis in a young child","volume":"2015","author":"Steeples","year":"2015","journal-title":"BMJ Case Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/IAE.0b013e3181ff0d8f","article-title":"Efficacy of low-dose methotrexate treatment in birdshot chorioretinopathy","volume":"31","author":"Rothova","year":"2011","journal-title":"Retina"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/ICB.0000000000000767","article-title":"Treatment of refractory tubercular serpiginous\u2013like choroiditis with intravitreal methotrexate","volume":"15","author":"Tsui","year":"2021","journal-title":"Retin. Cases Brief Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.4049\/jimmunol.1390055","article-title":"Calcineurin Inhibitors: 40 Years Later, Can\u2019t Live Without","volume":"191","author":"Azzi","year":"2013","journal-title":"J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/archopht.1982.01030040124022","article-title":"Modulation of Experimental Autoimmune Uveitis With Cyclosporin A","volume":"100","author":"Nussenblatt","year":"1982","journal-title":"Arch. Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/jop.1985.1.369","article-title":"Cyclosporine Therapy for Uveitis: Long-Term Followup","volume":"1","author":"Nussenblatt","year":"1985","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2125.1999.00911.x","article-title":"Therapeutic drug monitoring of immunosuppressant drugs","volume":"47","author":"Johnston","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0161-6420(97)30328-5","article-title":"Cyclosporine Monitoring with Levels 6 Hours after the Morning Dose in Patients with Noninfectious Uveitis","volume":"104","author":"Rocha","year":"1997","journal-title":"Ophthalmology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2174\/0929867327666201006153202","article-title":"Cyclosporine A: Chemistry and Toxicity\u2014A Review","volume":"28","author":"Patocka","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1076\/ocii.6.2.101.4051","article-title":"Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis","volume":"6","author":"Kilmartin","year":"1998","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/archopht.123.5.634","article-title":"Cyclosporine vs Tacrolimus Therapy for Posterior and Intermediate Uveitis","volume":"123","author":"Murphy","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bjophthalmol-2017-310436","article-title":"Safety profile and efficacy of tacrolimus in the treatment of birdshot retinochoroiditis: A retrospective case series review","volume":"102","author":"Islam","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0002-9394(14)73645-1","article-title":"A Clinical Trial of FK506 in Refractory Uveitis","volume":"115","author":"Mochizuki","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09286580701585892","article-title":"Methods for Identifying Long-Term Adverse Effects of Treatment in Patients with Eye Diseases: The Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study","volume":"15","author":"Kempen","year":"2008","journal-title":"Ophthalmic Epidemiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ophtha.2013.01.031","article-title":"Analysis of a Novel Protocol of Pulsed Intravenous Cyclophosphamide for Recalcitrant or Severe Ocular Inflammatory Disease","volume":"120","author":"Suelves","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s10792-021-01763-8","article-title":"New pharmacotherapy options for noninfectious posterior uveitis","volume":"41","author":"Pleyer","year":"2021","journal-title":"Int. Ophthalmol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/ard.2004.025882","article-title":"Therapeutic use of infliximab in sight threatening uveitis: Retrospective analysis of efficacy, safety, and limiting factors","volume":"64","author":"Bodaghi","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10792-013-9801-z","article-title":"Successful treatment of an overlapping choriocapillaritis between multifocal choroiditis and acute zonal occult outer retinopathy (AZOOR) with adalimumab (Humira\u2122)","volume":"34","author":"Neri","year":"2014","journal-title":"Int. Ophthalmol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1111\/j.1755-3768.2009.01738.x","article-title":"Infliximab in serpiginous choroiditis","volume":"88","author":"Seve","year":"2010","journal-title":"Acta Ophthalmol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajo.2018.12.019","article-title":"Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients","volume":"200","author":"Mesquida","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/09273948.2016.1231331","article-title":"Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review","volume":"25","author":"Blanco","year":"2017","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in Patients with Active Noninfectious Uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_76","first-page":"375","article-title":"Adalimumab (HUMIRA): A review","volume":"2","author":"Scheinfeld","year":"2003","journal-title":"J. Drugs Dermatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/apt.12863","article-title":"Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis","volume":"40","author":"Wolf","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1182\/blood.V95.12.3900.012k14_3900_3908","article-title":"Biologic re-sponse of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate comple-ment-mediated cell lysis","volume":"95","author":"Golay","year":"2000","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/bjo.2006.0101477","article-title":"Tailoring biological treatment: Anakinra treatment of posterior uveitis associated with the CINCA syndrome","volume":"91","author":"Teoh","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/IAE.0000000000001690","article-title":"Twenty-four month follow-up of tocilizumab therapy for refractory uveitis-related macular edema","volume":"38","author":"Mesquida","year":"2018","journal-title":"Retina"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Zierhut, M., Pav\u00e9sio, C., Ohno, S., Or\u00e9fice, F., and Rao, N.A. (2016). Multiple Evanescent White Dot Syndrome (MEWDS). Intraocular Inflammation, Springer.","DOI":"10.1007\/978-3-540-75387-2"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ajo.2004.11.012","article-title":"Atypical Presentation of Multiple Evanescent White Dot Syndrome Involving Granular Lesions of Varying Size","volume":"139","author":"Khurana","year":"2005","journal-title":"Am. J. Ophthalmol."},{"key":"ref_83","first-page":"67","article-title":"A case of overlapping choriocapillaritis syndromes: Multimodal imaging ap-praisal","volume":"7","author":"Kuznetcova","year":"2012","journal-title":"J. Ophthalmic. Vis. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archopht.1968.00980050179005","article-title":"Acute Posterior Multifocal Placoid Pigment Epitheliopathy","volume":"80","author":"Gass","year":"1968","journal-title":"Arch. Ophthalmol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/IAE.0b013e3181a0bd15","article-title":"Acute posterior multifocal placoid pigment epitheliopathy","volume":"29","author":"Fiore","year":"2009","journal-title":"Retina"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajoc.2019.03.005","article-title":"Cyclosporine and prednisolone combination therapy as a potential therapeutic strategy for relentless placoid chorioretinitis","volume":"14","author":"Uraki","year":"2019","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"100574","DOI":"10.1016\/j.ajoc.2019.100574","article-title":"An atypical case of acute posterior multifocal placoid pigment epitheliopathy with recurrent strokes","volume":"16","author":"Berger","year":"2019","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1097\/IAE.0b013e31825620d6","article-title":"Acute posterior multifocal placoid pigment epitheliopathy: Role of TNF blocker in severe cases","volume":"32","author":"Mohammed","year":"2012","journal-title":"Retina"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5935\/0004-2749.20190045","article-title":"Intravitreal and posterior subtenon triamcinolone acetonide for severe acute posterior multifocal placoid pigment epitheliopathy","volume":"82","author":"Vianna","year":"2019","journal-title":"Arq. Bras. Oftalmol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"NP49","DOI":"10.1177\/1120672119883598","article-title":"Ellipsoid layer restoration after Ozurdex\u00ae treatment in a patient with acute posterior multifocal placoid pigment epitheliopathy","volume":"31","author":"Revenga","year":"2021","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/2008-322X.194141","article-title":"Idiopathic multifocal choroiditis","volume":"11","author":"Tavallali","year":"2016","journal-title":"J. Ophthalmic Vis. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/aos.14473","article-title":"The efficacy of corticoid-aparing immuno-modulatory therapy in treating patients with central multifocal choroiditis","volume":"98","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10792-009-9323-x","article-title":"Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunesuppressants: Interventional case series","volume":"30","author":"Neri","year":"2010","journal-title":"Int. Ophthalmol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ajo.2014.08.039","article-title":"Success with Single-Agent Immunosuppression for Multifocal Choroidopathies","volume":"158","author":"Goldberg","year":"2014","journal-title":"Am. J. Ophthalmol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1631\/jzus.B1700535","article-title":"An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration","volume":"19","author":"Feng","year":"2018","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0161-6420(91)32198-5","article-title":"Triple Agent Immunosuppression in Serpiginous Choroiditis","volume":"98","author":"Hooper","year":"1991","journal-title":"Ophthalmology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1076\/ocii.9.3.153.3962","article-title":"Long-term immunosuppressive treatment of serpiginous choroiditis","volume":"9","author":"Akpek","year":"2001","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.survophthal.2012.08.008","article-title":"Serpiginous Choroiditis and Infectious Multifocal Serpiginoid Choroiditis","volume":"58","author":"Khanamiri","year":"2013","journal-title":"Surv. Ophthalmol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/09273940500227192","article-title":"Intravenous Pulse Methylprednisolone Therapy for Acute Treatment of Serpiginous Choroiditis","volume":"14","author":"Markomichelakis","year":"2006","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/09273948.2016.1237663","article-title":"Short-term Intensive Immunosuppression: A Randomized, Three-arm Study of Intravenous Pulse Methylprednisolone and Cyclophosphamide in Macular Serpiginous Choroiditis","volume":"26","author":"Venkatesh","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/09273948.2016.1214737","article-title":"Treatment of Serpiginous Choroiditis with Chlorambucil: A Report of 17 Patients","volume":"26","author":"Ebrahimiadib","year":"2016","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/09273948.2013.859276","article-title":"Effectiveness of Adalimumab for Refractory Serpiginous Choroiditis","volume":"22","author":"Capote","year":"2014","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Noda, K., Oishi, A., Uji, A., Tanaka, S., and Tsujikawa, A. (2019). Limited efficacy of adalimumab in the acute phase of serpiginous choroiditis refractory to corticosteroid and cyclosporine, a case report. BMC Ophthalmol., 19.","DOI":"10.1186\/s12886-019-1104-3"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/S0161-6420(03)00619-5","article-title":"Presumed tubercular serpiginouslike choroiditis: Clinical presentations and management","volume":"110","author":"Gupta","year":"2003","journal-title":"Ophthalmology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4103\/ijo.IJO_536_19","article-title":"Dual lesion margins on fundus autofluorescence associated with paradoxical worsening following treatment for tubercular serpiginous-like choroiditis","volume":"68","author":"Pathengay","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ophtha.2020.01.008","article-title":"Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis\u2014Report 1: Guidelines for Initiating An-titubercular Therapy in Tubercular Choroiditis","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12348-022-00282-6","article-title":"Tuberculosis-related serpiginous choroiditis: Aggressive therapy with dual concomitant combination of multiple anti-tubercular and multiple immunosuppressive agents is needed to halt the progression of the disease","volume":"12","author":"Papasavvas","year":"2022","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.ophtha.2008.05.009","article-title":"Serpiginous Choroiditis","volume":"115","author":"Benito","year":"2008","journal-title":"Ophthalmology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/09273948.2012.761240","article-title":"Adalimumab in Serpiginous Choroiditis","volume":"21","author":"Molins","year":"2013","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ajoc.2019.03.002","article-title":"Acute syphilis posterior placoid chorioretinopathy: An infectious or autoimmune disease?","volume":"14","author":"Ormaechea","year":"2019","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.survophthal.2021.06.003","article-title":"Ocular syphilis","volume":"67","author":"Furtado","year":"2021","journal-title":"Surv. Ophthalmol."},{"key":"ref_112","first-page":"437","article-title":"The Jarisch-Herxheimer reaction in ocular syphilis","volume":"58","author":"Fathilah","year":"2003","journal-title":"Med. J. Malays."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/eop.12.63","article-title":"Vogt-Koyanagi-Harada disease","volume":"7","author":"Attia","year":"2012","journal-title":"Expert Rev. Ophthalmol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1590\/S0004-27492009000300028","article-title":"New insights into Vogt-Koyanagi-Harada disease","volume":"72","author":"Damico","year":"2009","journal-title":"Arq. Bras. Oftalmol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"705796","DOI":"10.3389\/fmed.2021.705796","article-title":"New Perspectives on the Immunopathogenesis and Treatment of Uveitis Associated With Vogt-Koyanagi-Harada Disease","volume":"8","author":"Struyf","year":"2021","journal-title":"Front. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s10792-016-0395-0","article-title":"Reappraisal of the management of Vogt\u2013Koyanagi\u2013Harada disease: Sunset glow fundus is no more a fatality","volume":"37","author":"Herbort","year":"2016","journal-title":"Int. Ophthalmol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s10792-018-0949-4","article-title":"Catching the therapeutic window of opportunity in early initial-onset Vogt\u2013Koyanagi\u2013Harada uveitis can cure the disease","volume":"39","author":"Herbort","year":"2018","journal-title":"Int. Ophthalmol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/02713683.2017.1383444","article-title":"Novel treatment regimen of Vogt\u2013Koyanagi\u2013Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents","volume":"43","author":"Yang","year":"2017","journal-title":"Curr. Eye Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41433-021-01573-3","article-title":"Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt\u2013Koyanagi\u2013Harada disease: An updated review","volume":"36","author":"Herbort","year":"2021","journal-title":"Eye"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.autrev.2016.04.001","article-title":"Vogt\u2013Koyanagi\u2013Harada syndrome: Perspectives for immunogenetics, multimodal imaging, and therapeutic options","volume":"15","author":"Preble","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1007\/s10792-020-01417-1","article-title":"Vogt\u2013Koyanagi\u2013Harada disease: Recurrence rates after initial-onset disease differ according to treatment modality and geographic area","volume":"40","author":"Herbort","year":"2020","journal-title":"Int. Ophthalmol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bjophthalmol-2017-311691","article-title":"Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids","volume":"103","author":"Nakayama","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"ref_123","first-page":"85","article-title":"Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of \u2018sunset glow fundus\u2019 in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease","volume":"95","author":"Dosari","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"ref_124","first-page":"e603","article-title":"The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease","volume":"90","author":"Hemachandran","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2147\/OPTH.S134977","article-title":"Clinical spectrum and management options in Vogt\u2013Koyanagi\u2013Harada disease","volume":"11","author":"Lodhi","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/JOCO.JOCO_190_20","article-title":"Vogt\u2013Koyanagi\u2013Harada is a curable autoimmune disease: Early diagnosis and immediate dual steroidal and non-steroidal immunosuppression are crucial prerequisites","volume":"32","author":"Herbort","year":"2020","journal-title":"J. Curr. Ophthalmol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajo.2006.02.049","article-title":"Evaluation of the Effect on Outcomes of the Route of Administration of Corticosteroids in Acute Vogt-Koyanagi-Harada Disease","volume":"142","author":"Read","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00417-014-2904-z","article-title":"High rate of clinical recurrence in patients with Vogt\u2013Koyanagi\u2013Harada disease treated with early high-dose corticosteroids","volume":"253","author":"Sakata","year":"2015","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajo.2020.07.036","article-title":"Vogt-Koyanagi-Harada Disease Managed With Immunomodulatory Therapy Within 3 Months of Disease Onset","volume":"220","author":"Oo","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10384-021-00878-w","article-title":"Comparison of combination therapy of prednisolone and cyclosporine with corticosteroid pulse therapy in Vogt\u2013Koyanagi\u2013Harada disease","volume":"66","author":"Ono","year":"2021","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12348-020-00214-2","article-title":"Initial-onset acute and chronic recurrent stages are two distinctive courses of Vogt-Koyanagi-Harada disease","volume":"10","author":"Urzua","year":"2020","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41433-020-1072-0","article-title":"Advances and potential new developments in imaging techniques for posterior uveitis. Part 1: Noninvasive imaging methods","volume":"35","author":"Herbort","year":"2021","journal-title":"Eye"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41433-020-1072-0","article-title":"Advances and potential new developments in imaging techniques for posterior uveitis Part 2: Invasive imaging methods","volume":"35","author":"Herbort","year":"2021","journal-title":"Eye"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09273940500536766","article-title":"Immunomodulatory Therapy for Vogt-Koyanagi-Harada Patients as First-Line Therapy","volume":"14","author":"Paredes","year":"2006","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1111\/aos.12648","article-title":"Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease","volume":"93","author":"Urzua","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/09273948.2012.728668","article-title":"Comparison of Two Different Combination Immunosuppressive Therapies in the Treatment of Vogt-Koyonagi-Harada Syndrome","volume":"21","author":"Arcinue","year":"2013","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ajo.2016.06.004","article-title":"Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies","volume":"168","author":"Shen","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"ref_138","first-page":"474","article-title":"The Effect of Low-dose Cyclo-sporine (100 mg Once Daily) for Chronic Vogt-Koyanagi-Harada Disease","volume":"121","author":"Haruta","year":"2017","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"ref_139","first-page":"480","article-title":"Steroid Resistant Vogt-Koyanagi-Harada Disease Treated Effectively with Cyclosporine","volume":"121","author":"Fukutomi","year":"2017","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"ref_140","first-page":"225","article-title":"Corticotherapy vs. Corticotherapy Plus Immunosuppressive Therapy in Acute Vogt-Koyanagi-Harada Disease","volume":"93","year":"2018","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/09273940701624312","article-title":"The Use of Low-Dose Azathioprine in Patients with Vogt-Koyanagi-Harada Disease","volume":"15","author":"Kim","year":"2007","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/09273940600976938","article-title":"Triple Agent Immunosuppressive Therapy in Vogt-Koyanagi-Harada Syndrome","volume":"14","author":"Agarwal","year":"2006","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/09273941003587541","article-title":"Comparison of the Clinical Efficacy of Two Different Immunosuppressive Regimens in Patients with Chronic Vogt-Koyanagi-Harada Disease","volume":"18","author":"Cuchacovich","year":"2010","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09273940600557001","article-title":"Management of Pediatric Vogt-Koyanagi- Harada (VKH)-Associated Panuveitis","volume":"14","author":"Soheilian","year":"2006","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"300","DOI":"10.12659\/AJCR.914281","article-title":"Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt-Koyanagi-Harada Disease: A Multimodal Imaging Follow-Up Study","volume":"20","author":"Ingolotti","year":"2019","journal-title":"Am. J. Case Rep."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s10384-011-0092-5","article-title":"Chronic noninfectious uveitis associated with Vogt\u2013Koyanagi\u2013Harada disease treated with low-dose weekly systemic methotrexate","volume":"56","author":"Kondo","year":"2012","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/09273940802204527","article-title":"Infliximab Therapy for 2 Patients with Vogt-Koyanagi-Harada Syndrome","volume":"16","author":"Wang","year":"2008","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1136\/bjo.2008.153981","article-title":"Efficacy of infliximab therapy in two patients with refractory Vogt-Koyanagi-Harada disease","volume":"93","author":"Niccoli","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/09273941003739910","article-title":"Treatment of Pediatric Vogt-Koyanagi-Harada Syndrome with Infliximab","volume":"18","author":"Khalifa","year":"2010","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3109\/09273948.2013.775312","article-title":"Successful Use of Infliximab Therapy in Sight-threatening Corticosteroid-resistant Vogt-Koyanagi-Harada Disease","volume":"21","author":"Zmuda","year":"2013","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajoc.2018.06.022","article-title":"Long term treatment with infliximab in pediatric Vogt-Koyanagi-Harada disease","volume":"11","author":"Budmann","year":"2018","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12348-021-00251-5","article-title":"Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination","volume":"11","author":"Papasavvas","year":"2021","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_153","first-page":"131","article-title":"Tratamiento con Adalimumab -nuevo antiTNF- del s\u00edndrome de Vogt-Koyanagi-Harada [Adalimumab therapy for Vogt-Koyanagi-Harada syndrome]","volume":"82","author":"Llopis","year":"2007","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3928\/23258160-20140709-09","article-title":"Efficacy of Adalimumab for Pediatric Vogt-Koyanagi-Harada Syndrome","volume":"45","author":"Jeroudi","year":"2014","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/09273948.2016.1236969","article-title":"Adalimumab Treatment in Patients with Vogt\u2013Koyanagi\u2013Harada Disease","volume":"26","author":"Couto","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5152\/eurjrheum.2017.160085","article-title":"Anti-TNF? Therapy and switching in severe uveitis related to Vogt-Koyanagi-Harada syndrome","volume":"4","author":"Robles","year":"2017","journal-title":"Eur. J. Rheumatol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/09273948.2019.1603312","article-title":"Efficacy of Adalimumab for Chronic Vogt-Koyanagi-Harada Disease Refractory to Conventional Corticosteroids and Immunosuppressive Therapy and Complicated by Central Serous Chorioretinopathy","volume":"28","author":"Takayama","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3341\/kjo.2019.0052","article-title":"A Case of Recurrent Vogt-Koyanagi-Harada Disease Successfully Treated with Adalimumab in Young Female Adult Patient","volume":"34","author":"Kwon","year":"2020","journal-title":"Korean J. Ophthalmol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12348-011-0027-9","article-title":"Rituximab in refractory Vogt\u2013Koyanagi\u2013Harada disease","volume":"1","year":"2011","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s10067-014-2781-1","article-title":"Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease","volume":"34","author":"Caso","year":"2015","journal-title":"Clin. Rheumatol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/14397595.2015.1071234","article-title":"Rituximab for sight-threatening refractory pediatric Vogt\u2013Koyanagi\u2013Harada disease","volume":"28","author":"Umran","year":"2015","journal-title":"Mod. Rheumatol."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Abu El-Asrar, A.M., Dheyab, A., Khatib, D., Struyf, S., Van Damme, J., and Opdenakker, G. (Ocul. Immunol. Inflamm., 2020). Efficacy of B Cell Depletion Therapy with Rituximab in Refractory Chronic Recurrent Uveitis Associated with Vogt-Koyanagi-Harada Disease, Ocul. Immunol. Inflamm., epub ahead of print.","DOI":"10.1080\/09273948.2020.1820531"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Bolletta, E., Gozzi, F., Mastrofilippo, V., Pipitone, N., De Simone, L., Croci, S., Invernizzi, A., Adani, C., Iannetta, D., and Coassin, M. (2021). Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment. Ocul. Immunol. Inflamm., 1\u20136.","DOI":"10.1080\/09273948.2021.1880604"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jfma.2018.12.014","article-title":"A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab","volume":"118","author":"Su","year":"2019","journal-title":"J. Formos. Med Assoc."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Tedeschi, V., Paldino, G., Paladini, F., Mattorre, B., Tuosto, L., Sorrentino, R., and Fiorillo, M.T. (2020). The Impact of the \u2018Mis-Peptidome\u2019 on HLA Class I-Mediated Diseases: Contribution of ERAP1 and ERAP2 and Effects on the Immune Response. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249608"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/bjo.86.12.1439","article-title":"Histopathology of birdshot retinochoroidopathy","volume":"86","author":"Kaye","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2004-812827","article-title":"Differential Inflammatory Involvement in Retina and Choro\u00efd in Birdshot Chorioretinopathy","volume":"221","author":"Herbort","year":"2004","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/S0161-6420(99)90403-7","article-title":"Indocyanine green angiography in birdshot chorioretinopathy","volume":"106","author":"Fardeau","year":"1999","journal-title":"Ophthalmology"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/IAE.0000000000000967","article-title":"Birdshot chorioretinitis lesions on indocyanine green angiography as an indicator of disease activity","volume":"36","author":"Cao","year":"2016","journal-title":"Retina"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bjo.72.9.646","article-title":"Birdshot chorioretinopathy: Clinical characteristics and evolution","volume":"72","author":"Priem","year":"1988","journal-title":"Br. J. Ophthalmol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.83.2.241","article-title":"Birdshot retinochoroidopathy","volume":"83","author":"Gasch","year":"1999","journal-title":"Br. J. Ophthalmol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1001\/archopht.1984.01040030164018","article-title":"Birdshot Retinochoroidopathy","volume":"102","author":"Fuerst","year":"1984","journal-title":"Arch. Ophthalmol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ophtha.2003.09.031","article-title":"Birdshot chorioretinopathy: Long-term manifestations and visual prognosis","volume":"111","author":"Rothova","year":"2004","journal-title":"Ophthalmology"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s10792-018-1050-8","article-title":"Low-grade \u201cbenign\u201d birdshot retinochoroiditis: Prevalence and characteristics","volume":"39","author":"Lages","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0031-1299224","article-title":"Indocyanine Green Angiography (ICGA) is Essential for the Early Diagnosis of Birdshot Chorioretinopathy","volume":"229","author":"Papadia","year":"2012","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10792-013-9861-0","article-title":"Early and sustained treatment modifies the phenotype of birdshot retinochoroiditis","volume":"34","author":"Knecht","year":"2013","journal-title":"Int. Ophthalmol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10792-015-0046-x","article-title":"New concepts in the appraisal and management of birdshot retinochoroiditis, a global perspective","volume":"35","author":"Papadia","year":"2015","journal-title":"Int. Ophthalmol."},{"key":"ref_178","unstructured":"Maleki, A., Look-Why, S., Manhapra, A., Asgari, S., Philip, A.M., Chang, P.Y., Anesi, S.D., and Foster, C.S. (Can. J. Ophthalmol., 2021). Late recurrence in birdshot chorioretinopathy, Can. J. Ophthalmol., epub ahead of print."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0161-6420(13)31254-8","article-title":"Low-dose Cyclosporine Therapy in the Treatment of Birdshot Retinochoroidopathy","volume":"101","author":"Vitale","year":"1994","journal-title":"Ophthalmology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00417-012-2201-7","article-title":"Reappraisal of birdshot retinochoroiditis (BRC): A global approach","volume":"251","author":"Papadia","year":"2012","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1076\/0927-3948(200003)811-SFT049","article-title":"Intravenous immunoglobulin (IVIg) for the treat-ment of birdshot retinochoroidopathy","volume":"8","author":"LeHoang","year":"2000","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_182","first-page":"23","article-title":"Efficacit\u00e9 et tol\u00e9-rance des immunoglobulines intraveineuses dans le traitement de la r\u00e9tinochoro\u00efdopathie de type Birdshot [Efficacy of intravenous immunoglobulin in the treatment of Birdshot retinochoroiditis]","volume":"25","author":"Cassoux","year":"2002","journal-title":"J. Fr. Ophtalmol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ophtha.2004.12.036","article-title":"Long-term Follow-up of Patients with Birdshot Retinochoroidopathy Treated with Corticosteroid-Sparing Systemic Immunomodulatory Therapy","volume":"112","author":"Kiss","year":"2005","journal-title":"Ophthalmology"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/09273940490912407","article-title":"Long-Term Follow-Up of Patients with Birdshot Retinochoroidopathy Treated with Systemic Immunosuppression","volume":"13","author":"Becker","year":"2005","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/bjo.2007.120691","article-title":"Disappearance of classic birdshot spots after immunosuppression with tacrolimus and mycophenolate mofetil","volume":"92","author":"Leder","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/bjophthalmol-2012-302123","article-title":"Combined therapy of cyclosporine A and mycophenolate mofetil for the treatment of birdshot retinochoroidopathy: A 12-month follow-up","volume":"97","author":"Yilmaz","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/bjophthalmol-2014-305535","article-title":"Mycophenolic acid in the treatment of birdshot chorioretinopathy: Long-term follow-up","volume":"99","author":"Doycheva","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1080\/09273948.2019.1641610","article-title":"Long-term outcomes of systemic corticosteroid-sparing immunomodulatory therapy for Birdshot Retinochoroidopathy","volume":"28","author":"You","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archophthalmol.2007.49","article-title":"Daclizumab for Treatment of Birdshot Chorioretinopathy","volume":"126","author":"Sobrin","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1097\/IAE.0000000000002281","article-title":"Adalimumab therapy for refractory birdshot chorioretinopathy","volume":"39","author":"Veld","year":"2019","journal-title":"Retina"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s10792-017-0592-5","article-title":"Adalimumab in refractory cystoid macular edema associated with birdshot chorioretinopathy","volume":"38","author":"Steeples","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/j.jfo.2021.03.019","article-title":"Recurrence of inflammatory choroidal lesions on indocyanine green angiography despite adalimumab treatment as monotherapy in two patients with birdshot retinochoroidopathy: Report of two cases","volume":"45","author":"Mainguy","year":"2021","journal-title":"J. Fr. Ophtalmol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10067-018-4007-4","article-title":"Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: Two cases report and literature review","volume":"37","author":"Leclercq","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ophtha.2012.05.048","article-title":"Infliximab Treatment of Patients with Birdshot Retinochoroidopathy","volume":"120","author":"Artornsombudh","year":"2012","journal-title":"Ophthalmology"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1097\/IAE.0b013e31828396cf","article-title":"Postoperative outcomes after fluocinolone acetonide implant surgery in patients with birdshot chorioretinitis and other types of posterior and panuveitis","volume":"33","author":"Burkholder","year":"2013","journal-title":"Retina"},{"key":"ref_196","first-page":"234","article-title":"Evaluation of fluocinolone acetonide 0.19 mg intravitreal implant in the management of birdshot retinochoroiditis","volume":"106","author":"Testi","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ajo.2010.10.005","article-title":"Outcomes of Birdshot Chorioretinopathy Treated With an Intravitreal Sustained-Release Fluocinolone Acetonide\u2013Containing Device","volume":"151","author":"Rush","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1097\/IAE.0000000000000239","article-title":"Safety and efficacy of fluocinolone acetonide intravitreal implant (0.59 mg) in birdshot retinochoroidopathy","volume":"34","author":"Bajwa","year":"2014","journal-title":"Retina"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/ICB.0000000000000909","article-title":"Choroidal lesions unresponsive to fluocinolone acetonide intravitreal implant in birdshot chorioretinopathy","volume":"16","author":"Cheng","year":"2022","journal-title":"Retin. Cases Brief Rep."},{"key":"ref_200","first-page":"349","article-title":"Dexamethasone implantation in birdshot chorioretinopathy\u2014Long-term outcome","volume":"11","author":"Bajwa","year":"2018","journal-title":"Int. Med Case Rep. J."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/ICB.0000000000000287","article-title":"Intravitreal dexamethasone implantation for birdshot chorioretinopathy","volume":"11","author":"Walsh","year":"2017","journal-title":"Retin. Cases Brief Rep."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.oftal.2015.10.012","article-title":"Dexamethasone intravitreal implant for treatment of persistent macular oedema in Birdshot retinochoroidopathy","volume":"91","year":"2016","journal-title":"Arch. Soc. Esp. Oftalmol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jfo.2012.01.002","article-title":"Utilisation de l\u2019implant intravitr\u00e9en de dexam\u00e9thasone dans le traitement de la r\u00e9tinochoro\u00efdopathie de type birdshot [Role of intravitreal dexamethasone implant in the treatment of birdshot retinochoroidopathy]","volume":"35","author":"Terrada","year":"2012","journal-title":"J. Fr. Ophtalmol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1442-9071.2005.01048.x","article-title":"Use of intravitreal triamcinolone in the management of birdshot retinochoroidopathy associated with cystoid macular oedema: A case study over a three-year period","volume":"33","author":"Shah","year":"2005","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_205","first-page":"1380","article-title":"Intravitreal triamcinolone for refractory cystoid macular edema secondary to bird-shot retinochoroidopathy","volume":"119","author":"Martidis","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40942-016-0034-y","article-title":"Visual response and anatomical changes on sequential spectral-domain optical coherence tomography in birdshot chorioretinopathy treated with local corticosteroid therapy","volume":"2","author":"Gobuty","year":"2016","journal-title":"Int. J. Retin. Vitr."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/4\/398\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:42:44Z","timestamp":1760136164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/4\/398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":206,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["ph15040398"],"URL":"https:\/\/doi.org\/10.3390\/ph15040398","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]}}}